Morning Briefing
Summaries of health policy coverage from major news organizations
Indian Authorities Asked To Stop Licensing Artemisinin-Only Malaria Drugs
The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
